Kevin M.  Klemz net worth and biography

Kevin Klemz Biography and Net Worth

Kevin Klemz joined Silk Road Medical in August 2022 as our Chief Legal Officer and Corporate Secretary. Kevin brings over 35 years of legal experience, having spent the last 15 years as Chief Legal Officer to 3 different companies in the medtech sector. Most recently, Kevin served as EVP and Chief Legal Officer at Vyaire Medical, a global leader in the respiratory therapies space. For the 10 years prior to Vyaire Medical, Kevin was Chief Legal Officer at two different high-growth, public medtech companies. Tornier NV was a leader in the orthopedic extremities space prior to its acquisition by Wright Medical in 2015. ev3 was a leader in the peripheral vascular and neurovascular markets before its 2010 acquisition by Covidien plc. Kevin spent the first 20 years of his professional career in the private practice of law at the national law firm of Oppenheimer Wolff and Donnelly (now Fox Rothschild LLP). In the past, Kevin has also served on the Board of Directors of Gillette Children’s Specialty Healthcare. Kevin holds a B.A. in Business Administration from Hamline University and a J.D from William Mitchell College of Law.

What is Kevin M. Klemz's net worth?

The estimated net worth of Kevin M. Klemz is at least $4.48 million as of August 19th, 2024. Klemz owns 162,926 shares of Silk Road Medical stock worth more than $4,478,836 as of December 5th. This net worth approximation does not reflect any other investments that Klemz may own. Additionally, Klemz receives a salary of $644,120.00 as EVP at Silk Road Medical. Learn More about Kevin M. Klemz's net worth.

How old is Kevin M. Klemz?

Klemz is currently 63 years old. There are 5 older executives and no younger executives at Silk Road Medical. Learn More on Kevin M. Klemz's age.

What is Kevin M. Klemz's salary?

As the EVP of Silk Road Medical, Inc, Klemz earns $644,120.00 per year. There are 2 executives that earn more than Klemz. The highest earning executive at Silk Road Medical is Mr. Lucas W. Buchanan, CFO & COO, who commands a salary of $870,550.00 per year. Learn More on Kevin M. Klemz's salary.

How do I contact Kevin M. Klemz?

The corporate mailing address for Klemz and other Silk Road Medical executives is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. Silk Road Medical can also be reached via phone at (408) 720-9002 and via email at [email protected]. Learn More on Kevin M. Klemz's contact information.

Has Kevin M. Klemz been buying or selling shares of Silk Road Medical?

Kevin M. Klemz has not been actively trading shares of Silk Road Medical during the last ninety days. Most recently, Kevin M. Klemz sold 2,268 shares of the business's stock in a transaction on Monday, August 19th. The shares were sold at an average price of $27.10, for a transaction totalling $61,462.80. Following the completion of the sale, the executive vice president now directly owns 162,926 shares of the company's stock, valued at $4,415,294.60. Learn More on Kevin M. Klemz's trading history.

Who are Silk Road Medical's active insiders?

Silk Road Medical's insider roster includes Kevin Ballinger (Director), Lucas Buchanan (CFO), Andrew Davis (Insider), Kevin Klemz (EVP), Jack Lasersohn (Director), Erica Rogers (CEO), Richard Ruedy (EVP), and Elizabeth Weatherman (Director). Learn More on Silk Road Medical's active insiders.

Kevin M. Klemz Insider Trading History at Silk Road Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/19/2024Sell2,268$27.10$61,462.80162,926View SEC Filing Icon  
3/5/2024Sell2,497$17.17$42,873.49165,194View SEC Filing Icon  
8/17/2023Sell1,539$20.11$30,949.2938,797View SEC Filing Icon  
See Full Table

Kevin M. Klemz Buying and Selling Activity at Silk Road Medical

This chart shows Kevin M Klemz's buying and selling at Silk Road Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Silk Road Medical Company Overview

Silk Road Medical logo
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $27.49
Low: $27.49
High: $27.49

50 Day Range

MA: $27.31
Low: $27.01
High: $27.50

2 Week Range

Now: $27.49
Low: $6.08
High: $27.51

Volume

N/A

Average Volume

1,200,763 shs

Market Capitalization

$1.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53